Cargando…
Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare but serious side effect of nitrogen-containing bisphosphonate drugs (N-BPs) frequently prescribed to reduce skeletal-related events in bone malignancies and osteoporosis. BRONJ is associated with abnormal oral wound healin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445170/ https://www.ncbi.nlm.nih.gov/pubmed/36082175 http://dx.doi.org/10.1038/s43856-022-00172-x |
_version_ | 1784783368235253760 |
---|---|
author | Okawa, Hiroko Kondo, Takeru Hokugo, Akishige Cherian, Philip Sundberg, Oskar Campagna, Jesus J. Kashemirov, Boris A. John, Varghese Sun, Shuting Ebetino, Frank H. McKenna, Charles E. Nishimura, Ichiro |
author_facet | Okawa, Hiroko Kondo, Takeru Hokugo, Akishige Cherian, Philip Sundberg, Oskar Campagna, Jesus J. Kashemirov, Boris A. John, Varghese Sun, Shuting Ebetino, Frank H. McKenna, Charles E. Nishimura, Ichiro |
author_sort | Okawa, Hiroko |
collection | PubMed |
description | BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare but serious side effect of nitrogen-containing bisphosphonate drugs (N-BPs) frequently prescribed to reduce skeletal-related events in bone malignancies and osteoporosis. BRONJ is associated with abnormal oral wound healing after dentoalveolar surgery and tooth extraction. We previously found that N-BP chemisorbed to bone mineral hydroxyapatite was dissociated by secondary applied N-BP. This study investigated the effect of the surface equilibrium-based removal of N-BP from jawbone on tooth extraction wound healing of zoledronate (ZOL)-treated mice. METHODS: A pharmacologically inactive N-BP derivative (the 4-pyridyl isomer of risedronate equipped with a near-infrared 800CW fluorescent imaging dye, 800CW-pRIS) was designed and synthesized. 800CW-pRIS was intra-orally injected or topically applied in a deformable nano-scale vesicle formulation (DNV) to the palatal tissue of mice pretreated with ZOL, a potent N-BP. The female C56BL6/J mice were subjected to maxillary molar extraction and oral wound healing was compared for 800CW-pRIS/ZOL, ZOL and untreated control groups. RESULTS: 800CW-pRIS is confirmed to be inactive in inhibiting prenylation in cultured osteoclasts while retaining high affinity for hydroxyapatite. ZOL-injected mice exhibit delayed tooth extraction wound healing with osteonecrosis relative to the untreated controls. 800CW-pRIS applied topically to the jaw one week before tooth extraction significantly reduces gingival oral barrier inflammation, improves extraction socket bone regeneration, and prevents development of osteonecrosis in ZOL-injected mice. CONCLUSIONS: Topical pre-treatment with 800CW-RIS in DNV is a promising approach to prevent the complication of abnormal oral wound healing associated with BRONJ while retaining the anti-resorptive benefit of legacy N-BP in appendicular or vertebrate bones. |
format | Online Article Text |
id | pubmed-9445170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94451702022-09-07 Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice Okawa, Hiroko Kondo, Takeru Hokugo, Akishige Cherian, Philip Sundberg, Oskar Campagna, Jesus J. Kashemirov, Boris A. John, Varghese Sun, Shuting Ebetino, Frank H. McKenna, Charles E. Nishimura, Ichiro Commun Med (Lond) Article BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare but serious side effect of nitrogen-containing bisphosphonate drugs (N-BPs) frequently prescribed to reduce skeletal-related events in bone malignancies and osteoporosis. BRONJ is associated with abnormal oral wound healing after dentoalveolar surgery and tooth extraction. We previously found that N-BP chemisorbed to bone mineral hydroxyapatite was dissociated by secondary applied N-BP. This study investigated the effect of the surface equilibrium-based removal of N-BP from jawbone on tooth extraction wound healing of zoledronate (ZOL)-treated mice. METHODS: A pharmacologically inactive N-BP derivative (the 4-pyridyl isomer of risedronate equipped with a near-infrared 800CW fluorescent imaging dye, 800CW-pRIS) was designed and synthesized. 800CW-pRIS was intra-orally injected or topically applied in a deformable nano-scale vesicle formulation (DNV) to the palatal tissue of mice pretreated with ZOL, a potent N-BP. The female C56BL6/J mice were subjected to maxillary molar extraction and oral wound healing was compared for 800CW-pRIS/ZOL, ZOL and untreated control groups. RESULTS: 800CW-pRIS is confirmed to be inactive in inhibiting prenylation in cultured osteoclasts while retaining high affinity for hydroxyapatite. ZOL-injected mice exhibit delayed tooth extraction wound healing with osteonecrosis relative to the untreated controls. 800CW-pRIS applied topically to the jaw one week before tooth extraction significantly reduces gingival oral barrier inflammation, improves extraction socket bone regeneration, and prevents development of osteonecrosis in ZOL-injected mice. CONCLUSIONS: Topical pre-treatment with 800CW-RIS in DNV is a promising approach to prevent the complication of abnormal oral wound healing associated with BRONJ while retaining the anti-resorptive benefit of legacy N-BP in appendicular or vertebrate bones. Nature Publishing Group UK 2022-09-05 /pmc/articles/PMC9445170/ /pubmed/36082175 http://dx.doi.org/10.1038/s43856-022-00172-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Okawa, Hiroko Kondo, Takeru Hokugo, Akishige Cherian, Philip Sundberg, Oskar Campagna, Jesus J. Kashemirov, Boris A. John, Varghese Sun, Shuting Ebetino, Frank H. McKenna, Charles E. Nishimura, Ichiro Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
title | Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
title_full | Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
title_fullStr | Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
title_full_unstemmed | Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
title_short | Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
title_sort | fluorescent risedronate analogue 800cw-pris improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445170/ https://www.ncbi.nlm.nih.gov/pubmed/36082175 http://dx.doi.org/10.1038/s43856-022-00172-x |
work_keys_str_mv | AT okawahiroko fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT kondotakeru fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT hokugoakishige fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT cherianphilip fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT sundbergoskar fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT campagnajesusj fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT kashemirovborisa fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT johnvarghese fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT sunshuting fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT ebetinofrankh fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT mckennacharlese fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice AT nishimuraichiro fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice |